Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of VIVIMED LABS. For more details, see the VIVIMED LABS quarterly results and VIVIMED LABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -3.9 |
No. of shares | m | 82.91 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 13.8/4.9 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
VIVIMED LABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 82 | 27 | 24 | 42 | 17 | |
Low | Rs | 20 | 7 | 7 | 14 | 7 | |
Sales per share (Unadj.) | Rs | 159.4 | 127.7 | 103.9 | 28.6 | 22.6 | |
Earnings per share (Unadj.) | Rs | 7.0 | -13.2 | -8.7 | -8.2 | -39.6 | |
Diluted earnings per share | Rs | 6.9 | -13.2 | -8.7 | -8.2 | -39.6 | |
Cash flow per share (Unadj.) | Rs | 15.0 | -5.1 | -2.0 | -6.0 | -26.5 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 114.4 | 100.7 | 52.1 | 43.9 | 4.8 | |
Adj. book value per share | Rs | 113.8 | 100.7 | 52.1 | 43.9 | 4.8 | |
Shares outstanding (eoy) | m | 82.52 | 82.91 | 82.91 | 82.91 | 82.91 | |
Price / Sales ratio | x | 0.3 | 0.1 | 0.1 | 1.0 | 0.5 | |
Avg P/E ratio | x | 7.4 | -1.3 | -1.8 | -3.4 | -0.3 | |
P/CF ratio (eoy) | x | 3.4 | -3.3 | -7.8 | -4.7 | -0.5 | |
Price / Book Value ratio | x | 0.4 | 0.2 | 0.3 | 0.6 | 2.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 4,223 | 1,405 | 1,284 | 2,311 | 997 | |
Total wages/salary | Rs m | 2,418 | 2,334 | 1,897 | 362 | 327 |
VIVIMED LABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 13,152 | 10,588 | 8,615 | 2,373 | 1,871 | |
Other income | Rs m | 340 | 119 | 98 | 13 | 10 | |
Total revenues | Rs m | 13,491 | 10,707 | 8,713 | 2,386 | 1,881 | |
Gross profit | Rs m | 1,689 | 66 | 319 | -78 | -1,870 | |
Depreciation | Rs m | 668 | 669 | 555 | 183 | 1,084 | |
Interest | Rs m | 701 | 610 | 561 | 400 | 362 | |
Profit before tax | Rs m | 660 | -1,095 | -699 | -648 | -3,307 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 87 | -4 | 20 | 28 | -21 | |
Profit after tax | Rs m | 574 | -1,091 | -719 | -677 | -3,285 | |
Gross profit margin | % | 12.8 | 0.6 | 3.7 | -3.3 | -99.9 | |
Effective tax rate | % | 13.1 | 0.3 | -2.9 | -4.3 | 0.6 | |
Net profit margin | % | 4.4 | -10.3 | -8.3 | -28.5 | -175.6 |
VIVIMED LABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 12,306 | 9,753 | 5,287 | 5,073 | 3,323 | |
Current liabilities | Rs m | 8,889 | 7,700 | 3,411 | 3,734 | 4,243 | |
Net working cap to sales | % | 26.0 | 19.4 | 21.8 | 56.4 | -49.2 | |
Current ratio | x | 1.4 | 1.3 | 1.6 | 1.4 | 0.8 | |
Inventory Days | Days | 1 | 30 | 84 | 306 | 389 | |
Debtors Days | Days | 99 | 86 | 46 | 134 | 150 | |
Net fixed assets | Rs m | 10,918 | 12,206 | 7,606 | 7,587 | 6,561 | |
Share capital | Rs m | 3,417 | 3,418 | 166 | 166 | 166 | |
"Free" reserves | Rs m | 6,021 | 4,928 | 4,150 | 3,477 | 228 | |
Net worth | Rs m | 9,438 | 8,346 | 4,316 | 3,643 | 394 | |
Long term debt | Rs m | 4,248 | 4,708 | 578 | 610 | 623 | |
Total assets | Rs m | 23,224 | 21,959 | 12,893 | 12,660 | 9,883 | |
Interest coverage | x | 1.9 | -0.8 | -0.2 | -0.6 | -8.1 | |
Debt to equity ratio | x | 0.5 | 0.6 | 0.1 | 0.2 | 1.6 | |
Sales to assets ratio | x | 0.6 | 0.5 | 0.7 | 0.2 | 0.2 | |
Return on assets | % | 5.5 | -2.2 | -1.2 | -2.2 | -29.6 | |
Return on equity | % | 6.1 | -13.1 | -16.7 | -18.6 | -833.4 | |
Return on capital | % | 9.9 | -3.7 | -2.8 | -5.8 | -289.4 | |
Exports to sales | % | 14.6 | 7.0 | 4.1 | 0 | 0.9 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 1,922 | 745 | 357 | 0 | 17 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 1,922 | 745 | 357 | 0 | 17 | |
Fx outflow | Rs m | 535 | 770 | 312 | 0 | 0 | |
Net fx | Rs m | 1,386 | -26 | 44 | -0 | 17 |
VIVIMED LABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 4,221 | 796 | 5,673 | 275 | 353 | |
From Investments | Rs m | -889 | -1,960 | 4,040 | -164 | -50 | |
From Financial Activity | Rs m | -3,378 | 724 | -10,153 | -104 | -338 | |
Net Cashflow | Rs m | -45 | -440 | -441 | 8 | -34 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Bhagvanth Rao Mamidpalli | COMP SEC: Yugandhar Kopparthi | YEAR OF INC: 1988 | BSE CODE: 532660 | FV (Rs): 2 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare VIVIMED LABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.